References
- Henschke N, Kamper SJ, Maher CG. The epidemiology and economic consequences of pain. Mayo Clin Proc. 2015;90(1):139–147. doi:10.1016/j.mayocp.2014.09.010
- Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011;11:770. doi:10.1186/1471-2458-11-770
- Barth KS, Guille C, McCauley J, Brady KT. Targeting practitioners: a review of guidelines, training, and policy in pain management. Drug Alcohol Depend. 2017;173:S22–30.
- Kumar N. WHO normative guidelines on pain management. Geneva: World Health Organization; 2007. Available from: http://www.ayurvedar.com/images/delphi_study_pain_guidelines.pdf. Accessed November 22, 2022.
- Hagen M, Alchin J. Nonprescription drugs recommended in guidelines for common pain conditions. Pain Manag. 2020;10(2):117–129.
- Toms L, McQuay HJ, Derry S, Moore RA. Single dose oral paracetamol (Acetaminophen) for postoperative pain in adults. Cochrane Database Syst Rev. 2008;2008(4):CD004602.
- American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–631.
- Raffa RB, Pergolizzi JV, Taylor R, Decker JF, Patrick JT. Acetaminophen (paracetamol) oral absorption and clinical influences. Pain PracT. 2014;14(7):668–677.
- Forrest JAH, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin Pharmacokinet. 1982;7(2):93–107.
- Srinivas NR. Acetaminophen absorption kinetics in altered gastric emptying: establishing a relevant pharmacokinetic surrogate using published data. null. 2015;29(2):115–119.
- Kuo P, Rayner CK, Horowitz M. Gastric emptying, diabetes, and aging. Clin Geriatr Med. 2007;23(4):785–808. doi:10.1016/j.cger.2007.06.009
- Borsheski R, Johnson QL. Pain management in the geriatric population. Mo Med. 2014;111(6):508–511.
- Dostalek M, Akhlaghi F, Puzanovova M. Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs. Clin Pharmacokinet. 2012;51(8):481–499. doi:10.2165/11631900-000000000-00000
- Soenen S, Rayner CK, Horowitz M, Jones KL. Gastric emptying in the elderly. Clin Geriatr Med. 2015;31(3):339–353. doi:10.1016/j.cger.2015.04.003
- Gainsborough N, Maskrey VL, Nelson ML, et al. The association of age with gastric emptying. Age Ageing. 1993;22(1):37–40. doi:10.1093/ageing/22.1.37
- Wilson CG, Clarke CP, Starkey YYL, Clarke GD. Comparison of a novel fast-dissolving Acetaminophen tablet formulation (FD-APAP) and standard Acetaminophen tablets using gamma scintigraphy and pharmacokinetic studies. null. 2011;37(7):747–753.
- Yue Y, Reed K, Shneyer L, Liu DJ. Efficacy and safety of two fast-absorbing formulations of paracetamol in combination with caffeine for episodic tension-type headache: results from two randomized placebo- and active-controlled trials. Open Access Journal of Clinical Trials; 2017. Available from: https://www.dovepress.com/efficacy-and-safety-of-two-fast-absorbing-formulations-of-paracetamol--peer-reviewed-fulltext-article-OAJCT. Accessed November 22, 2022.
- GlaxoSmithKline Consumer Healthcare. Panadol original tablets - Summary of Product Characteristics (SmPC) - (emc); 2019. Available from: https://www.medicines.org.uk/emc/product/6474/smpc. Accessed November 22, 2022.
- GlaxoSmithKline Consumer Healthcare. New Zealand data sheet | PANADOL® tablets with optizorb® formulation, paracetamol 500mg, tablet; 2017. Available from: https://www.medsafe.govt.nz/profs/Datasheet/p/Panadoloptizorbtabcaplets.pdf. Accessed November 22, 2022.
- de Villiers MR, de Villiers PJT, Kent AP. The Delphi technique in health sciences education research. null. 2005;27(7):639–643.
- Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008–1015.
- IASP Terminology. IASP terminology – IASP; 2018. Available from: https://www.iasp-pain.org/Education/Content.aspx?ItemNumber=1698. Accessed November 22, 2022.
- Global pain index 2017- Research report. GSK consumer healthcare; 2017. Available from: https://www.gsk.com/media/3814/global-pain-index-2017-report.pdf. Accessed November 22, 2022.
- Schofield P. Pain in older adults: epidemiology, impact and barriers to management. Rev Pain. 2007;1(1):12–14. doi:10.1177/204946370700100104
- Kaye AD, Baluch A, Scott JT. Pain management in the elderly population: a review. Ochsner J. 2010;10(3):179–187.
- Heuch I, Heuch I, Hagen K, Sørgjerd EP, Åsvold BO, Zwart JA. Is chronic low back pain a risk factor for diabetes? The Nord-Trøndelag Health Study. BMJ Open Diabetes Res Care. 2018;6(1):1. doi:10.1136/bmjdrc-2018-000569
- Robinson K. Men, not women with diabetes may have higher chronic lower back pain risk. Endocrinology Network; 2019. Available from: https://www.endocrinologynetwork.com/article/men-not-women-diabetes-may-have-higher-chronic-lower-back-pain-risk-0. Accessed November 22, 2022.
- Wyatt LH, Ferrance RJ. The musculoskeletal effects of diabetes mellitus. J Can Chiropr Assoc. 2006;50(1):43–50.
- Kathleen K. OTC pain medications: the pros and cons. Pharmacy Times; 2017. Available from: https://www.pharmacytimes.com/publications/issue/2017/august2017/otc-pain-medications-The-pros-and-cons. Accessed November 22, 2022.
- Koch K. (PDF) Chronic pain management options in general practice; 2014. Available from: https://www.researchgate.net/publication/271673734_Chronic_pain_management_options_in_general_practice. Accessed November 22, 2022.
- BMJ Publishing Group Ltd. What dose of paracetamol for older people? DTB. 2018;56(6):69–72.
- Marcum ZA, Duncan NA, Makris UE. Pharmacotherapies in geriatric chronic pain management. Clin Geriatr Med. 2016;32(4):705–724.
- Liukas A, Kuusniemi K, Aantaa R, et al. Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet. 2011;50(2):121–129.
- Wynne HA, Cope LH, Herd B, Rawlins MD, James OF, Woodhouse KW. The association of age and frailty with paracetamol conjugation in man. Age Ageing. 1990;19(6):419–424.
- Saragiotto BT, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016;2016(6):1.
- Marathe CS, Rayner CK, Jones KL, Horowitz M. Relationships between gastric emptying, postprandial glycemia, and incretin hormones. Diabetes Care. 2013;36(5):1396–1405.
- Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001;24(7):1264–1269.
- Horowitz M, Maddern GJ, Chatterton BE, Collins PJ, Harding PE, Shearman DJC. Changes in Gastric Emptying Rates with Age. Clin Sci. 1984;67(2):213–218.
- Hughes SG. Prescribing for the elderly patient: why do we need to exercise caution? Br J Clin Pharmacol. 1998;46(6):531–533.
- Jane PF. Literature review of gastrointestinal physiology in the elderly, in pediatric patients, and in patients with gastrointestinal diseases | request PDF; 2015. Available from: https://www.researchgate.net/publication/283511919_Literature_Review_of_Gastrointestinal_Physiology_in_the_Elderly_in_Pediatric_Patients_and_in_Patients_with_Gastrointestinal_Diseases. Accessed November 22, 2022.
- Giarratano A, Green SE, Nicolau DP. Review of antimicrobial use and considerations in the elderly population. Clin Interv Aging. 2018;13:657–667.
- Dumic I, Nordin T, Jecmenica M, Stojkovic Lalosevic M, Milosavljevic T, Milovanovic T. Gastrointestinal tract disorders in older age. Can J Gastroenterol Hepatol. 2019;2019:1.
- Graham GG, Scott KF, Day RO. Tolerability of paracetamol. Drug Saf. 2005;28(3):227–240.
- Hunt RH, Choquette D, Craig BN, et al. Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs? Can Fam Physician. 2007;53(7):1177–1184.
- Matzke GR. Nonrenal toxicities of Acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents. Am J Kidney Dis. 1996;28(1 Suppl 1):S63–70.
- Singh G. Gastrointestinal complications of prescription and over-The-counter nonsteroidal anti-inflammatory drugs: a view from the ARAMIS database. Arthritis, rheumatism, and aging medical information system. Am J Ther. 2000;7(2):115–121.
- García Rodríguez LA, Hernández-Díaz S. Relative risk of upper gastrointestinal complications among users of Acetaminophen and nonsteroidal anti-inflammatory drugs. Epidemiology. 2001;12(5):570–576.
- Lanza FL, Codispoti JR, Nelson EB. An endoscopic comparison of gastroduodenal injury with over-The-counter doses of ketoprofen and Acetaminophen. Am J Gastroenterol. 1998;93(7):1051–1054.
- Lewis SC, Langman MJS, Laporte JR, Matthews JNS, Rawlins MD, Wiholm BE. Dose–response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol. 2002;54(3):320–326.
- McLachlan AJ, Bath S, Naganathan V, et al. Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol. 2011;71(3):351–364.
- Horowitz M, Wishart JM, Jones KL, Hebbard GS. Gastric emptying in diabetes: an overview. Diabet Med. 1996;13(9 Suppl 5):S16–22.
- Savvas S, Gibson S. Pain management in residential aged care facilities. Aust Fam Physician. 2015;44:198–203.
- Roumie CL, Griffin MR. Over-the-counter analgesics in older adults. Drugs Aging. 2004;21(8):485–498.
- Kim J, Kinney K, Nyquist M, Capellari E, Vordenberg SE. Factors that influence how adults select oral over-the-counter analgesics: a systematic review. J Am Pharm Assoc. 2022;62(4):1113–1123.e8.
- Peck J, Urits I, Peoples S, et al. A comprehensive review of over the counter treatment for chronic low back pain. Pain Ther. 2021;10(1):69–80.
- Buffum M, Buffum JC. Nonsteroidal anti-inflammatory drugs in the elderly. Pain Manag Nurs. 2000;1(2):40–50.
- Alchin J, Dhar A, Siddiqui K, Christo PJ. Why paracetamol (Acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older. Curr Med Res Opin. 2022;38(5):811–825.
- Blonde L, Khunti K, Harris SB, Meizinger C, Skolnik NS. Interpretation and impact of real-world clinical data for the practicing clinician. Adv Ther. 2018;35(11):1763–1774.
- Corrigan-Curay J, Sacks L, Woodcock J. Real-world evidence and real-world data for evaluating drug safety and effectiveness. JAMA. 2018;320(9):867–868.
- Gupta S, Atcheson R. Opioid and chronic non-cancer pain. J Anaesthesiol Clin Pharmacol. 2013;29(1):6–12.
- Manchikanti L, Helm S 2nd, Fellows B, et al. Opioid epidemic in the United States. Pain Physician. 2012;15(3Suppl):ES9–38.
- Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943–1953.
- Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85–92.
- Roxburgh A, Bruno R, Larance B, Burns L. Prescription of opioid analgesics and related harms in Australia. Med J Aust. 2011;195(5):280–284.
- Gautam S, Franzini L, Mikhail OI, Chan W, Turner BJ. Longitudinal analysis of opioid analgesic dose and diabetes quality of care measures. Pain Med. 2015;16(11):2134–2141.
- Chau DL, Walker V, Pai L, Cho LM. Opiates and elderly: use and side effects. Clin Interv Aging. 2008;3(2):273–278.
- Hasler WL, Wilson LA, Nguyen LA, et al. Opioid use and potency are associated with clinical features, quality of life, and use of resources in patients with gastroparesis. Clin Gastroenterol Hepatol. 2019;17(7):1285–1294.e1.
- Javed S, Petropoulos IN, Alam U, Malik RA. Treatment of painful diabetic neuropathy. Ther Adv Chronic Dis. 2015;6(1):15–28.
- Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH. Prevention and management strategies for diabetic neuropathy. Life. 2022;12(8):1185.
- Price R, Smith D, Franklin G, et al. Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN guideline subcommittee. Neurology. 2022;98(1):31–43.
- Jin J, Sklar GE, Min Sen Oh V, Chuen Li S. Factors affecting therapeutic compliance: a review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269–286.
- World Medical Association. WMA - the world medical association-WMA declaration of Helsinki – ethical principles for medical research involving human subjects; 2018. Available from: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed November 22, 2022.